ACE inhibitors in patients with acute myocardial infarction

ACE inhibitors in patients with acute myocardial infarction

The article is devoted to modern perspectives of ACE inhibitor therapy in patients with acute myocardial infarction (AMI). ACE inhibitor efficacy is analyzed, according to the results of large randomized studies. These trials have demonstrated ACE inhibitors’ positive effects on cardiovascular event...

Full description

Bibliographic Details
Main Authors:	S. N. Tereshchenko, N. A. Dzhaiani
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2005-08-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	инфаркт миокарда ингибиторы ангиотензин-превращающего фермента сердечнососудистые события
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/987

Similar Items

ACE inhibitor zofenopril in treatment of myocardial infarction patients: review of SMILE Project trials
by: Yu. M. Lopatin
Published: (2006-04-01)

PRESTIGE study: ACE inhibitors efficacy in patients with acute myocardial infarction and left ventricular dysfunction
by: Yu. N. Belenkov, et al.
Published: (2005-04-01)

Clinical role of cardioprotective and vasculoprotective effects of АСЕ inhibitors in myocardial infarction: zofenopril
by: G. K. Кiyakbaev
Published: (2008-12-01)

ACE inhibitors: new perspectives in cardiovascular disease treatment
by: V. I. Makolkin
Published: (2005-10-01)

New potential of ACE inhibitors in clinical practice
by: D. V. Nebieridze, et al.
Published: (2010-10-01)

ACE inhibitors in arterial hypertension management: zofenopril – class-specific effects and extra benefits
by: V. S. Zadionchenko, et al.
Published: (2007-04-01)

Pharmacology of modern ACE inhibitors: moexipril example
by: D. P. Khloponin, et al.
Published: (2007-10-01)

Cardiovascular disease and ACE inhibitors: focusing on enalapril
by: G. A. Baryshnikova
Published: (2007-12-01)

ACE inhibitor cilazapril: its place in cardiovascular diseases treatment
by: G. A. Baryshnikova
Published: (2005-08-01)

Safety and efficacy of the sulfydryl ACE-inhibitor zofenopril in the management of cardiovascular disease
by: C. Napoli
Published: (2011-12-01)

ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN ACUTE MYOCARDIAL INFARCTION: WHEN TO START THERAPY AND WHICH DRUG TO USE?
by: S. Y. Martsevich, et al.
Published: (2015-12-01)

Pleiotropic ACE inhibitor effects: any benefits for sulfhydryl agents?
by: D. V. Preobrazhensky, et al.
Published: (2008-02-01)

Levels of cytokines and C-reactive protein as treatment effectiveness criteria in patients with coronary heart disease and chronic heart failure
by: E. Yu. Sazhina, et al.
Published: (2008-06-01)

Perindopril arginine: a new ACE inhibitor salt increases therapeutic potential
by: Yu. A. Karpov
Published: (2008-12-01)

Comparative effectiveness of ACE inhibitors spirapril, fosinopril, and enalapril in complex therapy of patients with coronary heart disease, chronic obstructive pulmonary disease, and arterial hypertension
by: M. A. Popova, et al.
Published: (2006-06-01)

Effects of the fixed-dose combination therapy with indapamide and valsartan on renal function in patients with Type 2 diabetes mellitus and arterial hypertension
by: T. V. Malykh, et al.
Published: (2011-12-01)

EFFECT OF SPIRAPRIL ON THE LENGTH OF INTERICTAL INTERVAL IN PAROXYSMAL ATRIAL FIBRILLATION
by: L. N. Chikhireva, et al.
Published: (2015-12-01)

New perspectives in coronary heart disease management
by: V. I. Makolkin
Published: (2005-02-01)

Moexipril in arterial hypertension treatment among postmenopausal women with osteoporosis
by: O. D. Ostroumova, et al.
Published: (1970-01-01)

POTENTIAL OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN THE TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND CORONARY HEART DISEASE
by: A. G. Evdokimova, et al.
Published: (2013-02-01)

ACE inhibitors in arterial hypertension treatment among various clinical groups
by: O. D. Ostroumova, et al.
Published: (1970-01-01)

Inflammation role in atrial fibrillation pathogenesis
by: A. I. Tarzimanova, et al.
Published: (1970-01-01)

Endothelial dysfunction in arterial hypertension - cardiovascular complication risk factor
by: B. A. Namakanov, et al.
Published: (2005-12-01)

Angiotensin II type 1 receptor antagonists and ACE inhibitors in the regulation of hemodynamics and renin-angiotensin-aldosterone system activity: focus on the organ protection
by: M. L. Maksimov, et al.
Published: (2010-04-01)

Endothelial dysfunction in arterial hypertension: focus on the combination of trandolapril and verapamil
by: V. I. Makolkin
Published: (2010-08-01)

Heart diastolic dysfunction in patients with familial arterial hypertension
by: B. A. Namakanov, et al.
Published: (2005-06-01)

ВЛИЯНИЕ КОМБИНИРОВАННОЙ ТЕРАПИИ НА ЦЕНТРАЛЬНОЕ АРТЕРИАЛЬНОЕ ДАВЛЕНИЕ И АРТЕРИАЛЬНУЮ РИГИДНОСТЬ
Published: (2016-12-01)

ASSOCIATION BETWEEN ANTIHYPERTENSIVE AND LIPID-LOWERING THERAPY, BONE MASS, AND OSTEOPOROSIS RISK FACTORS
by: K. E. Sobchenko, et al.
Published: (2013-10-01)

AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND CALCIUM ANTAGONIST COMBINATION IN PHARMACOTHERAPY OF ARTERIAL HYPERTENSION
by: L. L. Kirichenko, et al.
Published: (2014-02-01)

Perindopril and hydrochlorthiazide effects on endothelium-dependent vasodilatation and angiotensin-converting enzyme activity in patients with mild to moderate arterial hypertension
by: T. V. Aparina, et al.
Published: (2005-06-01)

СОВРЕМЕННЫЕ ВОЗМОЖНОСТИ МЕДИКАМЕНТОЗНОЙ КОРРЕКЦИИ ЭНДОТЕЛИАЛЬНОЙ ДИСФУНКЦИИ У ПАЦИЕНТОВ С ИШЕМИЧЕСКОЙ БОЛЕЗНЬЮ СЕРДЦА В ИНТРАОПЕРАЦИОННОМ И РАННЕМ ПОСЛЕОПЕРАЦИОННОМ ПЕРИОДЕ ПОСЛЕ РЕВАСКУЛЯРИЗАЦИИ МИОКАРДА
by: R. E. Yakubtsevich, et al.
Published: (2022-03-01)

Left ventricular hypertrophy: renin4angiotensin system role
by: F. T. Ageev, et al.
Published: (2008-04-01)

Modern views on myocardial electric instability correction and prognosis improvement in coronary heart disease patients
by: V. V. Popov, et al.
Published: (2007-06-01)

Fixed-dose combination of perindopril and indapamide: perspectives in hypertensive patients with inadequately controlled blood pressure
by: I. E. Chazova, et al.
Published: (2007-02-01)

Vliyanie polimorfizma gena angiotenzin-I-prevrashchayushchego fermenta (APF) na antiproteinuricheskiy effekt ingibitorov APF u molodykh bol'nykh insulinzavisimym sakharnym diabetom
by: G I Sivous, et al.
Published: (1998-03-01)

A META-ANALYSIS REPORTING EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTSWITHOUT HEART FAILURE
by: G. Savarese, et al.
Published: (2015-09-01)

VESSEL WALL STIFFNESS IN ARTERIAL HYPERTENSION AND OPPORTUNITIES FOR ITS MODULATION
by: L. L. Kirichenko, et al.
Published: (2016-12-01)

SARTANS AND ANGIOTENSIN CONVERTING ENZYME INHIBITORS: A DUEL BETWEEN TWO LEADERS OF PHARMACOTHERAPY OF CARDIOVASCULAR DISEASES
by: K. A. Gyamdzhyan, et al.
Published: (2015-12-01)

Dynamics of the main parameters of structure-functional condition of the left ventricle myocardium in usage of combination antihypertension therapy for postmenopausal women with different obesity patterns
by: V. V. Skibitsky, et al.
Published: (2016-04-01)

COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS WITH HEART FAILURE AND PRESERVED SYSTOLIC FUNCTION: IS THERE A PLACE FOR AN INFORMED CHOICE?
by: I. V. Zhirov, et al.
Published: (2013-12-01)